Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase I Study Investigating the Safety of Stereotactic Body Radiotherapy (SBRT) With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Nivolumab (and other agents affecting the anti-programmed death-1 \[anti-PD-1\] pathway) have demonstrated anti-tumor activity in multiple tumor types. Combina…
MelanomaUnresectable Solid TumorsNeoplasms+7 more
Yana NajjarNCT04572451
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
ArthritisPolymyalgia RheumaticaImmune Checkpoint Inhibitors
M.D. Anderson Cancer CenterNCT06647134